These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16603829)

  • 1. Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes.
    Gosavi A; Flaker G; Gardner D
    Prev Cardiol; 2006; 9(2):102-7; quiz 108-9. PubMed ID: 16603829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia vs hyperglycemia.
    Feeman WE
    Prev Cardiol; 2007; 10(2):112. PubMed ID: 17392624
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials.
    Farmer JA
    Curr Atheroscler Rep; 2007 Aug; 9(2):162-8. PubMed ID: 17877926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How should we treat hypertension and dyslipidemia in patients with prediabetes?
    Tsimihodimos V; Florentin M; Elisaf MS
    Curr Pharm Des; 2013; 19(21):3773-87. PubMed ID: 23286438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
    Robins SJ
    Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrovascular Complications in Patients with Diabetes and Prediabetes.
    Huang D; Refaat M; Mohammedi K; Jayyousi A; Al Suwaidi J; Abi Khalil C
    Biomed Res Int; 2017; 2017():7839101. PubMed ID: 29238721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating lipid abnormalities in patients with type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2001 Dec; 88(12A):37N-40N. PubMed ID: 11788129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid disorders in type 2 diabetes.
    Laakso M
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():43-5. PubMed ID: 20629231
    [No Abstract]   [Full Text] [Related]  

  • 11. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus, insulin resistance, hyperglycemia, and stroke.
    Furie K; Inzucchi SE
    Curr Neurol Neurosci Rep; 2008 Jan; 8(1):12-9. PubMed ID: 18367034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes and dyslipidemia: Why are they so closely related?].
    Rašlová K
    Vnitr Lek; 2016; 62(11):908-911. PubMed ID: 28128578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Osue T; Kinutani H; Konishi A; Takahashi H; Terashita D; Uzu K; Hirata K
    Cardiovasc Diabetol; 2015 Jun; 14():78. PubMed ID: 26062762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?
    Steiner G
    Treat Endocrinol; 2005; 4(5):311-7. PubMed ID: 16185099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lipids and type 2 diabetes.
    Hermayer KL
    Curr Cardiol Rep; 2004 Nov; 6(6):443-50. PubMed ID: 15485606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of High Intensity Statin Therapy in the Treatment of Diabetic Dyslipidemia in Patients with Coronary Artery Disease.
    Vavlukis M; Kedev S
    Curr Pharm Des; 2018; 24(4):427-441. PubMed ID: 29283060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and LDL lowering: the need for intensive therapy.
    Del Prato S
    Curr Vasc Pharmacol; 2012 Nov; 10(6):687-9. PubMed ID: 23259554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes.
    Karalis DG
    Clin Cardiol; 2008 Jun; 31(6):241-8. PubMed ID: 17847038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Dyslipidemia in Type 2 Diabetes.
    Nelson AJ; Nicholls SJ
    Cardiol Clin; 2018 May; 36(2):233-239. PubMed ID: 29609753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.